Skip to main content
Premium Trial:

Request an Annual Quote

HTG Molecular Diagnostics 2021 Revenues Grow 5 Percent

NEW YORK – HTG Molecular Diagnostics reported after the close of the market on Tuesday that its 2021 revenues edged up 5 percent to $8.9 million from $8.5 million a year ago.

Revenue related to products and product-related services made up all of HTG's revenues in 2021, and increased 13 percent year over year from $7.9 million. In 2020, HTG also recorded $658,000 in collaborative development services revenue.

The Tucson, Arizona-based company said that revenues from its HTG Transcriptome Panel (HTP) accounted for about 16 percent of total revenue in 2021, five months after its commercial launch.

HTG recorded a net loss of $17.1 million, or $2.47 per share, in 2021, compared to a net loss of $20.9 million, or $4.51 per share, in 2020. The firm used approximately 6.9 million shares to calculate per-share loss in 2021 compared to about 4.6 million shares in 2020.

The firm's 2021 R&D expenses were flat year over year at $6.1 million, while its SG&A spending dropped 9 percent to $16.5 million from $18.1 million a year ago.

HTG finished the year with $9.6 million in cash and cash equivalents and $12.3 million in short-term investments available for sale.

In March, HTG completed a private placement of its securities, generating gross proceeds of about $7.5 million.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.